Brain (and spinal cord) tumours
Open
Phase 2
This trial is looking at whether having a drug called Sativex with temozolomide works better than temozolomide on its own for glioblastoma.
It is open to people with glioblastoma that has come back after .
Recruitment start: 3 February 2023
Recruitment end: 30 April 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Susan Short
The Brain Tumour Charity
GW Pharma/Jazz Pharmaceuticals (provide Sativex and placebo free of charge)
Cancer Research UK Clinical Trials Unit (CRCTU) Birmingham
University of Birmingham
University of Leeds
Last reviewed: 4 June 2025
CRUK internal database number: 18081
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
